Michael Douglas

Medicine & Life Sciences

1. 4-hydroxy-5-nitrophenyl acetic acid 14%
2. Actin Depolymerizing Factors 17%
3. Apoptosis 24%
4. Axons 60%
5. Blood Platelets 43%
6. C-Type Lectins 19%
7. Central Nervous System 37%
8. Cerebrospinal Fluid 44%
9. citron-kinase 24%
10. Diagnosis-Related Groups 13%
11. ErbB Receptors 23%
12. Growth 26%
13. Guillain-Barre Syndrome 15%
14. Heparitin Sulfate 15%
15. Immunoglobulin Light Chains 16%
16. Immunoreceptor Tyrosine-Based Inhibition Motif 35%
17. Integrins 13%
18. Megakaryocytes 33%
19. Metabolomics 13%
20. Multiple Sclerosis 100%
21. Myelin Sheath 32%
22. Nerve Growth Factors 20%
23. Nervous System Trauma 18%
24. Neuroglia 23%
25. Neuronal Outgrowth 29%
26. Neurons 18%
27. Non-Receptor Type 6 Protein Tyrosine Phosphatase 23%
28. opicinumab 26%
29. Osmotic Pressure 14%
30. Parkinsonian Disorders 13%
31. Pericytes 15%
32. phosphatidylinositol 3,5-diphosphate 21%
33. Phospholipase C gamma 18%
34. Platelet Endothelial Cell Adhesion Molecule-1 17%
35. Primary Myelofibrosis 19%
36. Proteins 13%
37. Regeneration 33%
38. Retinal Ganglion Cells 45%
39. RTKI cpd 16%
40. Sedentary Behavior 13%
41. sialic acid receptor 20%
42. Spinal Ganglia 30%
43. Spinal Injections 15%
44. src-Family Kinases 16%
45. Stromal Cells 24%
46. Survivin 14%
47. T-Lymphocytes 16%
48. Th1 Cells 14%
49. Tyrosine 18%
50. Vascular Cell Adhesion Molecule-1 14%